Concepedia

Qing‐Tian Niu

QN

20

Publications

3.2K

Citations

20

H-Index

2004

Active since

Affiliations

Amgen (United States)(Current)

UCB Pharma (United Kingdom)

Qing‐Tian Niu is an author at Amgen (United States) specializing in medicine, osteoporosis, and orthopaedics.

Top concepts

Publications per year

2004–2018

20

Publications

20

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

Xiaodong Li, Michael S. Ominsky, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2008 · 932 citations · Full text

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Xiaodong Li, Michael S. Ominsky, Kelly Warmington et al. · Journal of Bone and Mineral Research · 2008 · 773 citations

, , +17

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Xiaodong Li, Kelly Warmington, Qing‐Tian Niu et al. · Journal of Bone and Mineral Research · 2010 · 233 citations

, , +21

Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody

Michael S. Ominsky, Qing‐Tian Niu, Chaoyang Li et al. · Journal of Bone and Mineral Research · 2013 · 164 citations · Full text

Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury

Xiaodong Li, Mario Grisanti, Wei Fan et al. · Journal of Bone and Mineral Research · 2011 · 119 citations

Rows per page

1–5 of 20